BioStock: Saniona comments on the possible listing in the USA
On November 30, Saniona released its Q3 report and in addition to summing up important advances during the quarter, the report also made it clear that the biotechnology company is considering listing its share on Nasdaq USA. BioStock reached out to CEO Rami Levin at Saniona’s headquarters in Boston, Massachusetts, who told us more about the potential plans.Read the full interview with Rami Levin at biostock.se: https://www.biostock.se/en/saniona-comments-on-the-possible-listing-in-the-usa/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se